Concepedia

Lynda Coughlan

LC

Statistics

Publications

46

Citations

3.8K

H-Index

32

Active since

2009

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of Maryland, Baltimore

Jenner Institute

University of Glasgow

University of Oxford

Lynda Coughlan is an author at Icahn School of Medicine at Mount Sinai specializing in infectious diseases, viral vaccines, and immunology.

ORCID

Publications per year

2009–2025

46

Publications

46

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

Kris M. White, Romel Rosales, Soner Yildiz et al. · Science · 2021 · 364 citations · Full text

, , +17

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Raffael Nachbagauer, Jodi Feser, Abdollah Naficy et al. · Nature Medicine · 2020 · 358 citations

, , +14

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

Alec W. Freyn, Jamile Ramos da Silva, Victoria Rosado et al. · Molecular Therapy · 2020 · 310 citations · Full text

, , +17

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection

Raveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat et al. · Emerging Microbes & Infections · 2020 · 205 citations · Full text

, , +16

Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens

Richard Antrobus, Lynda Coughlan, Tamara Berthoud et al. · Molecular Therapy · 2013 · 198 citations · Full text

, , +17

1–5 of 46